BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo-Parke H, Linden D, Weldon S, Kidney JC, Taggart CC. Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation. Front Immunol 2020;11:1205. [PMID: 32655557 DOI: 10.3389/fimmu.2020.01205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Esteban-lopez M, Perry MD, Garbinski LD, Manevski M, Andre M, Ceyhan Y, Caobi A, Paul P, Lau LS, Ramelow J, Owens F, Souchak J, Ales E, El-hage N. Health effects and known pathology associated with the use of E-cigarettes. Toxicology Reports 2022;9:1357-68. [DOI: 10.1016/j.toxrep.2022.06.006] [Reference Citation Analysis]
2 Le Roux M, Ollivier A, Kervoaze G, Beke T, Gillet L, Pichavant M, Gosset P. IL-20 Cytokines Are Involved in Epithelial Lesions Associated with Virus-Induced COPD Exacerbation in Mice. Biomedicines 2021;9:1838. [PMID: 34944654 DOI: 10.3390/biomedicines9121838] [Reference Citation Analysis]
3 Tan ZX, Fu L, Wang WJ, Zhan P, Zhao H, Wang H, Xu DX. Serum CYR61 Is Associated With Airway Inflammation and Is a Potential Biomarker for Severity in Chronic Obstructive Pulmonary Disease. Front Med (Lausanne) 2021;8:781596. [PMID: 34917638 DOI: 10.3389/fmed.2021.781596] [Reference Citation Analysis]
4 Chen Y, Chang Y, Huang K, Hsu P, Hsiao C, Lin M. Unraveling the Pathogenesis of Asthma and Chronic Obstructive Pulmonary Disease Overlap: Focusing on Epigenetic Mechanisms. Cells 2022;11:1728. [DOI: 10.3390/cells11111728] [Reference Citation Analysis]
5 Alharbi KS, Fuloria NK, Fuloria S, Rahman SB, Al-Malki WH, Javed Shaikh MA, Thangavelu L, Singh SK, Rama Raju Allam VS, Jha NK, Chellappan DK, Dua K, Gupta G. Nuclear factor-kappa B and its role in inflammatory lung disease. Chem Biol Interact 2021;345:109568. [PMID: 34181887 DOI: 10.1016/j.cbi.2021.109568] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Chukowry PS, Spittle DA, Turner AM. Small Airways Disease, Biomarkers and COPD: Where are We? Int J Chron Obstruct Pulmon Dis 2021;16:351-65. [PMID: 33628018 DOI: 10.2147/COPD.S280157] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Guo-Parke H, Linden D, Weldon S, Kidney JC, Taggart CC. Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium. Medicina (Kaunas) 2022;58:121. [PMID: 35056429 DOI: 10.3390/medicina58010121] [Reference Citation Analysis]
8 Chen Y, Gong X, Zhou M, Xu Y, Fan F, Xiao J, Liu L, Shi K, Li S, Zhuo J, Chen Z, Yu X, Fan L, Chen Y, Wu L, Lin L. Treatment with JianPiYiFei II granules for patients with moderate to very severe chronic obstructive pulmonary disease: A 52-week randomised, double-blinded, placebo-controlled, multicentre trial. Phytomedicine 2022;100:154057. [PMID: 35349835 DOI: 10.1016/j.phymed.2022.154057] [Reference Citation Analysis]
9 Yu X, Cai T, Fan L, Liang Z, Du Q, Wang Q, Yang Z, Vlahos R, Wu L, Lin L. The traditional herbal formulation, Jianpiyifei II, reduces pulmonary inflammation induced by influenza A virus and cigarette smoke in mice. Clin Sci (Lond) 2021:CS20210050. [PMID: 34236078 DOI: 10.1042/CS20210050] [Reference Citation Analysis]
10 Cai Z, Wang Q, Xu J, Zhou J, Jiang Z, Pan D, Zhang Y, Tao L, Peng J, Chen Y, Shen X. Enhanced protective activity of 1,8-Cineole on emphysema using hyaluronic acid-coated liposomes via quantitative pulmonary administration in mice. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103402] [Reference Citation Analysis]
11 Liu J, Ran Z, Wang F, Xin C, Xiong B, Song Z. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease. Crit Rev Microbiol 2021;47:1-12. [PMID: 33040638 DOI: 10.1080/1040841X.2020.1830748] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Acevedo N, Escamilla-Gil JM, Espinoza H, Regino R, Ramírez J, Florez de Arco L, Dennis R, Torres-Duque CA, Caraballo L. Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19. Front Immunol 2021;12:678661. [PMID: 34335580 DOI: 10.3389/fimmu.2021.678661] [Reference Citation Analysis]